AJDRAJNR - American Journal of Neuroradiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, S. Y.
Right arrow Articles by Suh, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, S. Y.
Right arrow Articles by Suh, J. H.

American Journal of Neuroradiology, Vol 18, Issue 4 639-645, Copyright © 1997 by American Society of Neuroradiology


ARTICLES

Direct endovascular thrombolytic therapy for dural sinus thrombosis: infusion of alteplase

SY Kim and JH Suh
Department of Diagnostic Radiology, Ajou University, School of Medicine, Suwon, Korea.

PURPOSE: To evaluate the efficacy, safety, and results of direct thrombolytic therapy in intracranial dural sinus thrombosis by infusion of alteplase (recombinant tissue plasminogen activator). METHODS: Nine patients were treated during a 2-year period for intracranial dural sinus thrombosis. A microcatheter was placed directly into the thrombus in the dural sinus via the transfemoral route. Thrombolysis was initiated with a rapid injection of 10 mg of alteplase over 10 minutes, followed in 3 hours by a continuous infusion of 50 mg, then a continuous infusion at 5 mg per hour until complete thrombolysis or a total dose of 100 mg per day had been reached. Repeat thrombolysis was tried the following day if complete recanalization did not occur at 100 mg per day. RESULTS: Successful recanalization with improvement of symptoms was achieved in all cases. Time required for complete thrombolysis was between 8 and 43 hours. The total dose of alteplase ranged from 50 to 300 mg. Complications of a small intrapelvic hemorrhage and oozing at a femoral puncture site occurred in separate cases, but were not related to the amount of infused alteplase. MR venograms obtained 1 to 4 weeks after the procedure showed no evidence of reocclusion of the dural sinuses. CONCLUSION: Direct fibrinolytic therapy with alteplase is safe, fast, and effective in treating dural sinus thrombosis. However, to prevent hemorrhagic complications, further studies are required to determine its optimal dose and proper rate of administration.


This article has been cited by other articles:


Home page
Am. J. Neuroradiol.Home page
D.V. La Barge III, F.S. Bishop, E.A. Stevens, R. Eskandari, R.H. Schmidt, E.J. Skalabrin, and P.P. Ng
Intrasinus Catheter-Directed Heparin Infusion in the Treatment of Dural Venous Sinus Thrombosis
AJNR Am. J. Neuroradiol., October 1, 2009; 30(9): 1672 - 1678.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
M. Wasay and A. K. Kamal
Anticoagulation in Cerebral Venous Sinus Thrombosis: Are We Treating Ourselves?
Arch Neurol, July 1, 2008; 65(7): 985 - 987.
[Full Text] [PDF]


Home page
StrokeHome page
J. Stam, C. B.L.M. Majoie, O. M. van Delden, K. P. van Lienden, and J. A. Reekers
Endovascular Thrombectomy and Thrombolysis for Severe Cerebral Sinus Thrombosis: A Prospective Study
Stroke, May 1, 2008; 39(5): 1487 - 1490.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
E. Stolz, T. Gerriets, R. H. Bodeker, M. Hugens-Penzel, and M. Kaps
Intracranial Venous Hemodynamics Is a Factor Related to a Favorable Outcome in Cerebral Venous Thrombosis
Stroke, June 1, 2002; 33(6): 1645 - 1650.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
J. Kimber
Cerebral venous sinus thrombosis
QJM, March 1, 2002; 95(3): 137 - 142.
[Full Text] [PDF]


Home page
StrokeHome page
M. Wasay, R. Bakshi, S. Kojan, G. Bobustuc, N. Dubey, D.H. Unwin, P. Gates, and R. Gerraty
Nonrandomized Comparison of Local Urokinase Thrombolysis Versus Systemic Heparin Anticoagulation for Superior Sagittal Sinus Thrombosis Editorial Comment
Stroke, October 1, 2001; 32(10): 2310 - 2317.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
L. Liang, Y. Korogi, T. Sugahara, M. Onomichi, Y. Shigematsu, D. Yang, M. Kitajima, Y. Hiai, and M. Takahashi
Evaluation of the Intracranial Dural Sinuses with a 3D Contrast-enhanced MP-RAGE Sequence: Prospective Comparison with 2D-TOF MR Venography and Digital Subtraction Angiography
AJNR Am. J. Neuroradiol., March 1, 2001; 22(3): 481 - 492.
[Abstract] [Full Text]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
S F T M de Bruijn, R J de Haan, and J Stam
Clinical features and prognostic factors of cerebral venous sinus thrombosis in a prospective series of 59 patients
J. Neurol. Neurosurg. Psychiatry, January 1, 2001; 70(1): 105 - 108.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
H T S BENAMER and I BONE
Cerebral venous thrombosis: anticoagulants or thrombolyic therapy?
J. Neurol. Neurosurg. Psychiatry, October 1, 2000; 69(4): 427 - 430.
[Full Text] [PDF]


Home page
StrokeHome page
K. Chow, Y. P. Gobin, J. Saver, C. Kidwell, P. Dong, and F. Vinuela
Endovascular Treatment of Dural Sinus Thrombosis With Rheolytic Thrombectomy and Intra-Arterial Thrombolysis
Stroke, June 1, 2000; 31(6): 1420 - 1425.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
H. Allroggen and R. J Abbott
Cerebral venous sinus thrombosis
Postgrad. Med. J., January 1, 2000; 76(891): 12 - 15.
[Abstract] [Full Text]


Home page
StrokeHome page
M.-G. Bousser
Cerebral Venous Thrombosis : Nothing, Heparin, or Local Thrombolysis?
Stroke, March 1, 1999; 30(3): 481 - 483.
[Full Text] [PDF]


Home page
StrokeHome page
J. L. Frey, G. J. Muro, C. G. McDougall, B. L. Dean, and H. K. Jahnke
Cerebral Venous Thrombosis : Combined Intrathrombus rtPA and Intravenous Heparin
Stroke, March 1, 1999; 30(3): 489 - 494.
[Abstract] [Full Text] [PDF]